Pengju Xu

11PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 27, 2025
A prospective study of tumor-stroma ratio in resected intrahepatic mass-forming cholangiocarcinoma: prognostic value and correlation with gadoxetic acid-enhanced MRI.

Yi-Jun Pan, Ling-Li Chen, Zheng Wang

|Oct 10, 2025
LI-RADS nonradiation treatment response assessment version 2024: diagnostic performance in HCC treated with transarterial chemoembolization.

Di Wang, Rong Lyu, Yang Zhang

|Apr 12, 2024
Intra- and Peri-tumoral Radiomics Based on Dynamic Contrast Enhanced-MRI to Identify Lymph Node Metastasis and Prognosis in Intrahepatic Cholangiocarcinoma.

Yi-Jun Pan, Sun-Jie Wu, Yan Zeng

|Apr 11, 2024
LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features.

Di Wang, Yang Zhang, Rong Lyu

|Oct 13, 2023
MRI-based radiomics signature: a potential imaging biomarker for prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma.

Guofeng Zhou, Yang Zhou, Xun Xu

|Feb 07, 2022
DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.

Yang Zhou, Guofeng Zhou, Jiulou Zhang

Pageof 2

Frequent Collaborators

1 joint publications

Jiang Lin

1 joint publications

Yujen Tseng

1 joint publications

Shiyao Chen